Ep. 207 - Are Cancer Detecting Blood Tests Ready For Prime Time? Here’s What The Galleri Test Can Actually Do
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Ep. 207 - Are Cancer Detecting Blood Tests Ready For Prime Time? Here’s What The Galleri Test Can Actually Do
-
Lu par :
-
De :
À propos de ce contenu audio
Are cancer detecting blood tests finally ready for real world use? Dr. Dean Mitchell sits down with Dr. Eric Klein, a distinguished scientist at GRAIL and former Cleveland Clinic chair, to walk through the promise and the limits of the Galleri multi cancer early detection blood test. They break down how the test looks for cancer related DNA using methylation patterns, why it can often predict where a cancer started, and what happens next if a cancer signal is detected. You’ll also hear how Galleri fits alongside standard screenings like mammograms, colonoscopy, PSA, and Cologuard, plus a clear explanation of sensitivity versus positive predictive value and why false positives matter. They also explore who may benefit most from testing, why age is the biggest risk factor, what the real false positive rate looks like, and how long a negative result may offer peace of mind.
Contact Dr. Mitchell:
Email: care@mitchellmedicalgroup.com
Website
YouTube
Order your copy of Dr. Mitchell’s latest book, Conquering Candida, here.
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !